Order results by:
| Issue | Title | |
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
| Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
| "... six regions of the Russian Federation, receiving interferon beta-1a 44 μg, interferon beta-1b ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... SinnoVex is a drug from the group of bioanalogues of interferon beta-1a for intramuscular ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... . Material and methods. MS patients (n=40) receiving interferon-β (IFNβ) therapy who showed a suboptimal ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
| A. N. Boyko | ||
| "... with interferon-β drugs due to pegylation is discussed. Without losing its effectiveness, sampeginterferon beta-1a ..." | ||
| Vol 15 (2023): (Suppl. 1) | The evolution of interferon therapy in multiple sclerosis | Abstract similar documents |
| O. V. Boyko, N. F. Smirnova, A. N. Boyko | ||
| "... The article reviews the evolution of interferon-β (IFN-β) in the treatment of multiple sclerosis ..." | ||
| Vol 16 (2024): (Suppl. 2) | Sampeginterferon beta-1a in clinical practice | Abstract similar documents |
| I. A. Sokolova, O. S. Kornakova, E. V. Sokolova | ||
| "... ) into clinical practice can improve treatment outcomes. Interferon beta drugs are commonly used as DMTs. Among ..." | ||
| Online-first | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... in patients under 18 years of age with a relapsing-remitting MS (RRMS). In the first observation, a 16-year ..." | ||
| Vol 17, No 1 (2025) | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... in patients under 18 years of age with a relapsing-remitting MS (RRMS). In the first observation, a 16-year ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Review of human interferons and the potential of their use in the complex therapy of a new coronavirus infection COVID-19 | Abstract similar documents |
| E. V. Granatov, A. R. Abashev, F. A. Khabirov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... Interferons (IFNs) were first discovered over 60 years ago in a classic experiment by Isaacs ..." | ||
| Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
| "... analyses were performed for intramuscular interferon (INF)-β1a (avonex, 30 μg), subcutaneous INF-β1a (rebif ..." | ||
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... curcumin on clinical and immunological parameters in MS patients receiving interferon (IFN) therapy ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... with those of healthy people and patients with a typical course of relapsingremitting MS (RRMS). Patients ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... MS (RRMS), 9.1±4.2 years in secondary progressive MS (SPMS), and 2.7±1.9 years in primary progressive ..." | ||
| Vol 11, No 1 (2019) | Anti-MOG syndrome: two case reports | Abstract PDF (Eng) similar documents |
| A. S. Kotov | ||
| "... occurred during interferon-β therapy. In the other case the syndrome also began with optic neuritis ..." | ||
| Vol 14, No 2 (2022) | Changes in expression of miRNAs from the DLK1-DIO3 locus are characteristic of relapsing-remitting multiple sclerosis regardless of the disease activity | Abstract similar documents |
| N. M. Baulina, A. R. Kabaeva, A. N. Boyko, O. O. Favorova | ||
| "... in the expression of 26 microRNA genes localized in the DLK1-DIO3 locus in men with relapsing-remitting MS (RRMS ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| "... multiple sclerosis (RRMS) in remission. Material and methods. 38 patients with RRMS were analyzed (33 women ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... (RRMS), which is used as an immune reconstitution therapy. A population-based cohort study was conducted ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis | Abstract similar documents |
| Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko | ||
| "... , and a higher level of fatigue than patients with relapsing-remitting MS (RRMS). Another unfavorable course ..." | ||
| Vol 10, No 2 (2018) | Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative-dystrophic diseases of the joints and spine: results of proteomic analysis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. N. Gromov | ||
| "... the synthesis of IgA, the migration of leukocytes, and the activity of hematopoietin and interferon receptors ..." | ||
| Vol 7, No 2 (2015) | Brain bioelectrical activity changes in patients with poststroke depression and apathy | Abstract similar documents |
| I. V. Kichuk, E. A. Petrova, N. A. Georgievskaya | ||
| "... ЭЭГ в бета-диапазоне отмечалась отсроченно. ..." | ||
| Vol 15, No 6 (2023) | Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” (October 1, 2023). Main conclusions of the first meeting | Abstract similar documents |
| A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha | ||
| "... помощи в этих странах. Сампэгинтерферон бета-1а (самПЭГ-ИФН-β1a) является эффективным и безопасным ..." | ||
| Vol 7, No 1 (2015) | Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use | Abstract similar documents |
| I. D. Stolyarov, A. M. Petrov, M. V. Votintseva, I. G. Nikiforova | ||
| "... development of medicine. Due to the fact that most of them belong to interferons-β, i.e. biologicals ..." | ||
| Vol 14, No 4 (2022) | The role of oxidative stress in the development of Alzheimer's disease | Abstract similar documents |
| V. N. Nikolenko, N. A. Rizaeva, K. V. Bulygin, V. M. Anokhina, A. A. Bolotskaya | ||
| "... , воспаление, нарушение регуляции гомеостаза металлов, неправильный фолдинг белков. Нами рассмотрена роль бета ..." | ||
| Vol 11, No 1 (2019) | Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus | Abstract similar documents |
| B. G. Adleyba, G. V. Gavrilov, A. V. Stanishevsky, B. V. Gaydar, D. V. Svistov, V. Yu. Lobzin, K. A. Kolmakova | ||
| "... соответствии с данными литературы являются: бета-амилоид (Aβ) 42, Aβ-40, Aβ-38, sAPPα, sAPPβ, белки t-tau и p ..." | ||
| Vol 11, No 1 (2019) | Primary progressive aphasia | Abstract PDF (Eng) similar documents |
| V. A. Mikhailov, Yu. V. Kotsiubinskaya, N. Yu. Safonova, N. I. Ananieva, I. K. Stulov | ||
| Vol 8, No 3 (2016) | Changes in EEG indices and serotonin concentrations in depression and anxiety disorders | Abstract similar documents |
| I. V. Kichuk, E. A. Petrova, A. A. Mitrofanov, N. V. Solovyeva, V. B. Vilyanov | ||
| "... спектральных характеристик ЭЭГ в бета-диапазоне. При когерентном анализе в бета-диапазоне отмечались ..." | ||
| Vol 16, No 5 (2024) | Resolution of the Expert Council on the problem of early diagnosis of Alzheimer's disease | Abstract similar documents |
| A. N. Bogolepova, E. E. Vasenina, N. V. Vakhnina, S. V. Vorobyеv, S. I. Gavrilova, А. Yu. Emelin, V. V. Zakharov, S. N. Illarioshkin, O. V. Kosivtsova, G. P. Kostyuk, O. S. Levin, E. A. Mkhitaryan, V. А. Parfenov, O. N. Tkacheva, Yu. A. Shpilyukova | ||
| Vol 14, No 2 (2022) | New potential biomarkers of Alzheimer's disease: markers of endothelial dysfunction and neuroinflammation. | Abstract similar documents |
| A. K. Minochkin, V. Yu. Lobzin, N. N. Suchentseva, O. S. Popov, S. V. Apalko, S. G. Sherbak | ||
| "... the concentration of growth/differentiation factor 15 and interferon γ in blood plasma and FAB scores in patients ..." | ||
| Vol 12, No 2 (2020) | Systematic analysis of the molecular pathophysiology of tenosynovitis: promise for using chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. M. Lila, O. A. Limanova | ||
| "... of proinflammatory cytokines (IL-1, IL-8, γ-interferon, and TNF-α), monocyte chemoattractant protein-1 (MCP-1 ..." | ||
| Vol 9, No 1 (2017) | Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region | Abstract similar documents |
| V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev | ||
| "... and interferons were most frequently prescribed as DMDs for MS in the region. Conclusion. The findings may ..." | ||
| Vol 15, No 3 (2023) | Inflammatory biomarkers and growth factors in patients with chronic cerebrovascular disease after coronavirus infection | Abstract similar documents |
| E. B. Kuznetsova, O. N. Voskresenskaya, N. B. Zakharova, N. S. Kuznetsov | ||
| "... in blood serum – tumor necrosis factor α (TNF α ), interleukin 6 (IL6), IL18, interferon γ (IFN γ ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) | Abstract similar documents |
| M. A. Omarova, M. S. Kozin, A. N. Boyko | ||
| "... развился ремиттирующий РС (РРС), и тех, у кого длительное время оставался КИС, получены следующие ..." | ||
| Vol 8, No 2 (2016) | Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... -remitting MS (RRMS). The safety profile of GA 40 mg was completely consistent with the well-known profile ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... -прогрессирующем (ВПРС) фенотипах РС. Пациенты и методы. Обследовано 80 пациентов: с РРС (n=48) и ВПРС (n=32 ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
| Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
| "... : интерферон бета1а (n=2), глатирамера ацетат (n=5). Проведена ретроспективная оценка течения эпилепсии и РС ..." | ||
| Vol 17, No 2 (2025) | Differences in cerebrospinal fluid microRNA profiles in patients with remitting multiple sclerosis and patients with other neurological diseases | Abstract similar documents |
| М. А. Omarova, М. S. Kozin, А. N. Boyko | ||
| "... ремиттирующим рассеянным склерозом (РРС) в стадии ремиссии и пациентов с другими неврологическими заболеваниями ..." | ||
| Vol 16 (2024): (Suppl. 2) | Cytokine levels in patients with multiple sclerosis and chronic neuroborreliosis | Abstract similar documents |
| N. S. Baranova, L. A. Ovsyannikova, Ya. S. Ostapenko, N. N. Spirin, A. A. Baranov, M. S. Gris, A. S. Artyukhov, Yu. V. Manyakina | ||
| "... , IL17F, IL21, IL22, IL23, IL25, IL31, IL33, interferon γ (IFNγ), tumor necrosis factor α (TNFα ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... in the fact that there are various types, such as relapsing-remitting MS (RRMS), primary and secondary ..." | ||
| Vol 3, No 4 (2011) | New criteria for diagnosing Alzheimer's disease | Abstract similar documents |
| A. Yu. Emelin | ||
| "... диагностику с использованием лабораторных и нейровизуализационных маркеров бета-амилоида, нейронального ..." | ||
| Vol 16, No 2 (2024) | Diagnosis of Alzheimer's disease by using biological markers in posterior cortical atrophy | Abstract similar documents |
| D. A. Grishina, N. A. Khayalieva, V. V. Grinyuk, A. Yu. Tyurina | ||
| "... бета-амилоида в цереброспинальной жидкости, что позволило установить диагноз БА. Обсуждаются ..." | ||
| Vol 8, No 1 (2016) | Migraine and neck pain: Mechanisms of comorbidity | Abstract similar documents |
| A. S. Zenkevich, E. G. Filatova, N. V. Latysheva | ||
| "... головной боли 3-го пересмотра, версия бета, 2013 г. (МКГБ-3 бета). Для оценки функции антиноцицептивных ..." | ||
| Vol 16, No 2 (2024) | Alzheimer's disease: diagnosis and treatment, errors in patient management | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. Yu. Tyurina | ||
| "... биологических маркеров заболевания, отражающих патологическое образование бета-амилоида и тау-протеина в ..." | ||
| Vol 13, No 1 (2021) | Modern approaches to drug treatment for vestibular vertigo | Abstract similar documents |
| M. V. Zamergrad, S. V. Morozova | ||
| "... – Бетасерк® Лонг), глюкокортикоидов и гентамицина – при болезни Меньера; триптанов, бета-адреноблокаторов ..." | ||
| Vol 9, No 4 (2017) | Current approaches to diagnosing and treating major neurocognitive disorder | Abstract similar documents |
| A. A. Kulesh, V. V. Shestakov | ||
| "... , позитронно-эмиссионная томография с индикатором амилоида, а также оценка содержания бета-амилоида и тау ..." | ||
| Vol 12, No 6 (2020) | Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes | Abstract similar documents |
| D. V. Ivashchenko, A. S. Osipov, E. V. Nazarova, M. A. Ovchinnikova, N. I. Buromskaya, V. V. Smirnov, P. V. Shimanov, R. V. Deitch, T. A. Fainshtein, E. N. Shagovenko, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... и на 14-е сутки исследования. Активность CYP3A оценивали по отношению концентрации 6-бета ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Genome-wide polygenic analysis of multiple sclerosis markers | Abstract similar documents |
| Ya. R. Timasheva, T. R. Nasibullin, I. A. Tuktarova, V. V. Erdman, T. R. Galiullin, O. V. Zaplakhova, K. Z. Bakhtiiarova | ||
| "... 9282641), факторов транскрипции SOX8 (rs2744148) и ZBTB46 (rs6062314), бета-маннозидазы MANBA (rs228614 ..." | ||
| Vol 14, No 6 (2022) | Alzheimer's disease and COVID-19 | Abstract similar documents |
| N. N. Koberskaya, F. A. Roshchin | ||
| "... , опосредованные глиальными клетками, что в свою очередь может привести к накоплению бета-амилоида и последующему ..." | ||
| Vol 12, No 4 (2020) | Diagnosis and treatment of migraine: Russian experts' recommendations | Abstract similar documents |
| E. G. Filatova, V. V. Osipova, G. R. Tabeeva, V. A. Parfenov, E. V. Ekusheva, Yu. E. Azimova, N. V. Latysheva, M. V. Naprienko, K. V. Skorobogatykh, A. V. Sergeev, V. A. Golovacheva, E. R. Lebedeva, A. R. Artyomenko, O. V. Kurushina, M. I. Koreshkina, A. V. Amelin, L. R. Akhmadeeva, A. R. Rachin, E. D. Isagulyan, Al. B. Danilov, A. B. Gekht | ||
| "... показана профилактическая терапия, которая включает антидепрессанты, антиконвульсанты, бета-блокаторы ..." | ||
| Vol 11, No 3 (2019) | he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments | Abstract similar documents |
| I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova, K. M. Naumov, I. A. Lupanov, G. A. Kilivaeva, M. R. Alizade | ||
| "... исследователи считали причиной болезни гиперпродукцию бета-амилоидного белка (Аβ), то в последние годы все чаще ..." | ||
| Vol 10, No 2 (2018) | Diagnostic criteria for transient ischemic attack | Abstract similar documents |
| E. R. Lebedeva, N. M. Gurary, J. Olesen | ||
| "... России (n=152), страдающих мигренью с аурой, у которых диагноз был установлен согласно МГКБ-3 бета ..." | ||
| Vol 16, No 3 (2024) | Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons | Abstract similar documents |
| K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov | ||
| "... маркеров (биомаркеров) БА: снижение уровня бета-амилоида (Ав1-42) и повышение уровня фосфорилированного тау ..." | ||
| Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
| "... также позитронно-эмиссионная томография (патологическое накопление бета-амилоида и тау-протеина в ..." | ||
| Vol 7, No 1 (2015) | Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region | Abstract similar documents |
| E. R. Lebedeva, N. R. Kobzeva, D. V. Gilev, E. Olesen | ||
| "... болей версии 3 бета. Результаты и обсуждение. Выявлены следующие факторы, снижающее качество ..." | ||
| 1 - 53 of 53 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
